Press Release

Some COVID-19 vaccine sites paused due to lack of supply

Both Moscone and City College sites will pause. No existing appointments will be cancelled. Moscone will pause for 1 week, and reopen once more vaccine supply is available. City College will resume on February 19 for second doses only.

The vaccine supply coming to San Francisco’s healthcare providers and the Department of Public Health is limited, inconsistent, and unpredictable, making vaccine roll out difficult and denying San Franciscans this potentially life-saving intervention.

With the opening of the City College and Moscone high volume vaccination sites, vaccines administered by healthcare providers, pharmacies, and DPH in San Francisco increased significantly to average 7,400 doses over the last 7 days. At the beginning of last week, we had vaccinated 31% of the 65 and older population, and we ended the week at 47%, nearly at the halfway mark.  San Francisco has the capacity to administer more than 10,000 vaccines per day but lack the vaccine supply.

The Moscone high volume site will pause for one week and will reopen once supply is sufficient to resume operations. Moscone is being operated in partnership with Kaiser Permanente and fellow consortium members Adventist Health, the CA Medical Association, Dignity Health, Futuro Health and the California Primary Care Association.

The City College high volume site, operated in partnership with UCSF, expects to resume on Friday for second doses only. The third high volume site will launch this week but with available appointments far below full capacity. No existing appointments were canceled; spots are only released for booking once the vaccine supply is confirmed.  

San Francisco—healthcare providers, pharmacies, and DPH—has to vaccinate more than 760,000 residents over the age of 16, requiring more than 1.5 million doses. As of February 13, San Francisco received 262,000 doses and administered over 190,000 doses to San Franciscans and surrounding Bay Area residents. This is a vaccine usage rate of 72.4%. The remaining vaccine doses are set aside for scheduled first appointments and scheduled second doses